- Latest available (Revised)
- Original (As enacted)
This version of this part contains provisions that are prospective.
The term provision is used to describe a definable element in a piece of legislation that has legislative effect – such as a Part, Chapter or section. A version of a provision is prospective either:
Commencement Orders listed in the ‘Changes to Legislation’ box as not yet applied may bring this prospective version into force.
There are currently no known outstanding effects for the Medicines and Medical Devices Act 2021, PART 2 .
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Prospective
2U.K.In the Medical Devices Regulations 2002 (S.I. 2002/618), after the last Schedule insert, with the appropriate number, the following Schedule—
Regulation 60A
The regulations referred to in regulation 60A(1) are—
Regulation | Description |
---|---|
8(1), (2) | Essential requirements for general medical devices |
10(1) to (5) | CE marking of general medical devices |
11 | CE marking of general medical devices within scope of more than one Directive |
13(1) to (4) | Procedures for affixing a CE marking to general medical devices |
14(1), (2), (5) | Procedures for systems and procedure packs, and for devices to be sterilised before use |
15 | Procedures for custom-made general medical devices |
16(1), (4), (7), (10) | Procedures for general medical devices for clinical investigation |
17(1), (2) | Manufacturers etc and conformity assessment procedures for general medical devices |
19 | Registration of persons placing general medical devices on the market |
22 | Essential requirements for active implantable medical devices |
24 | CE marking of active implantable medical devices |
25 | CE marking of active implantable medical devices within scope of more than one Directive |
27 | Procedures for affixing a CE marking to active implantable medical devices |
28 | Procedures for custom-made active implantable medical devices |
29(1), (3), (6), (7), (9) | Procedures for active implantable medical devices for clinical investigations |
30(1) | Manufacturers etc and conformity assessment procedures for active implantable medical devices |
34 | Essential requirements for in vitro diagnostic medical devices |
36(1) to (5) | CE marking of in vitro diagnostic medical devices |
37 | CE marking of in vitro diagnostic medical devices within scope of more than one Directive |
38 | In vitro diagnostic medical devices not ready for use |
40 | Procedures for affixing a CE marking to in vitro diagnostic medical devices |
41(1), (2), (3) | Manufacturers etc and conformity assessment procedures for in vitro diagnostic medical devices |
43 | Devices for performance evaluation |
44 | Registration of manufacturers etc of in vitro diagnostic medical devices and devices for performance evaluation |
50(1)(a) and (b), (2), (3) | Products incorrectly marked with a notified body or conformity assessment body number |
51(1), (2) | Products incorrectly marked with a CE marking” |
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Text created by the government department responsible for the subject matter of the Act to explain what the Act sets out to achieve and to make the Act accessible to readers who are not legally qualified. Explanatory Notes were introduced in 1999 and accompany all Public Acts except Appropriation, Consolidated Fund, Finance and Consolidation Acts.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: